Nischal Maheshwari, Head-Research at Edelweiss Securities is of the view that one may prefer Sun Pharmaceutical Industries as the stock is down almost 15 percent.
first published: Apr 27, 2015 11:36 am
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Over 150 Points From Day's High But Gains For 6th Day| IT Stocks Surge|Closing Bell Live
Jigar Mistry flags potential risk to markets and what investors need to be cautious about
Will Nifty Clinch All-Time High As GIFT Nifty Signals Big Gap Up? HUL Q2 Today| Opening Bell Live
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
